IMMUTEP COMPLETES $6.31 MILLION SHARE PURCHASE PLAN; RAISES...

IMMUTEP COMPLETES $6.31 MILLION SHARE PURCHASE PLAN; RAISES TOTAL OF $13.16 MILLION SYDNEY, AUSTRALIA - Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) advises that its Share Purchase Plan (“SPP”) closed as planned on 6 April 2018. The Company received applications from eligible shareholders for 300,561,089 new ordinary shares (“New Shares”) at the purchase price of $0.021 per New Share. Accordingly, the Company has raised A$6.31 million before transaction-related expenses through the SPP. This is in addition to A$6.85 million institutional placement announced on 12 March 2018, bringing the total funds raised from the SPP and institutional placement to A$ 13.16 million. The funds raised from the SPP and Placement will be used to support Immutep’s ongoing and planned immuno-oncology clinical development programs, its pre-clinical program in autoimmune disease and for general working capital purposes.

first 3 paragraphs for those who can't see it yet